Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome.

Grosso AF, de Oliveira SF, Higuchi Mde L, Favarato D, Dallan LA, da Luz PL.

Diabetol Metab Syndr. 2014 Mar 31;6(1):47. doi: 10.1186/1758-5996-6-47.

2.

Adipose tissue gene expression of adiponectin, tumor necrosis factor-α and leptin in metabolic syndrome patients with coronary artery disease.

Gormez S, Demirkan A, Atalar F, Caynak B, Erdim R, Sozer V, Gunay D, Akpinar B, Ozbek U, Buyukdevrim AS.

Intern Med. 2011;50(8):805-10. Epub 2011 Apr 15.

3.

Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.

Hanefeld M, Marx N, Pfützner A, Baurecht W, Lübben G, Karagiannis E, Stier U, Forst T.

J Am Coll Cardiol. 2007 Jan 23;49(3):290-7. Epub 2007 Jan 8.

4.

Role of epicardial adipose tissue in coronary artery disease in non-obese patients.

Iwayama T, Nitobe J, Watanabe T, Ishino M, Tamura H, Nishiyama S, Takahashi H, Arimoto T, Shishido T, Miyashita T, Miyamoto T, Toyama S, Sadahiro M, Kubota I.

J Cardiol. 2014 May;63(5):344-9. doi: 10.1016/j.jjcc.2013.10.002. Epub 2013 Nov 11.

5.

Inflammatory genes in epicardial fat contiguous with coronary atherosclerosis in the metabolic syndrome and type 2 diabetes: changes associated with pioglitazone.

Sacks HS, Fain JN, Cheema P, Bahouth SW, Garrett E, Wolf RY, Wolford D, Samaha J.

Diabetes Care. 2011 Mar;34(3):730-3. doi: 10.2337/dc10-2083. Epub 2011 Feb 2.

6.

Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis.

Du Y, Ji Q, Cai L, Huang F, Lai Y, Liu Y, Yu J, Han B, Zhu E, Zhang J, Zhou Y, Wang Z, Zhao Y.

Cardiovasc Diabetol. 2016 Jun 28;15:90. doi: 10.1186/s12933-016-0406-5.

7.

Enhanced inflammation in epicardial fat in patients with coronary artery disease.

Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, Nishio C, Higashida M, Nakaya Y, Kitagawa T, Sata M.

Int Heart J. 2011;52(3):139-42.

8.

Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.

Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, McTernan PG.

Cardiovasc Diabetol. 2006 Jan 13;5:1.

9.

Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease.

Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT.

Int J Obes (Lond). 2008 Feb;32(2):268-74. Epub 2007 Sep 18.

PMID:
17878891
10.

Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease.

Zhou Y, Wei Y, Wang L, Wang X, Du X, Sun Z, Dong N, Chen X.

Cardiovasc Diabetol. 2011 Jan 12;10:2. doi: 10.1186/1475-2840-10-2.

11.

Epicardial adipose tissue inflammation is related to vitamin D deficiency in patients affected by coronary artery disease.

Dozio E, Briganti S, Vianello E, Dogliotti G, Barassi A, Malavazos AE, Ermetici F, Morricone L, Sigruener A, Schmitz G, Corsi Romanelli MM.

Nutr Metab Cardiovasc Dis. 2015 Mar;25(3):267-73. doi: 10.1016/j.numecd.2014.08.012. Epub 2014 Sep 19.

PMID:
25315671
12.

Effects of simvastatin on systemic inflammatory responses after cardiopulmonary bypass.

TAMAYO E, ALVAREZ FJ, ALONSO O, BUSTAMANTE R, CASTRODEZA J, SORIA S, LAJO C.

J Cardiovasc Surg (Torino). 2009 Oct;50(5):687-94.

PMID:
19741581
13.

Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis.

Gao X, Mi S, Zhang F, Gong F, Lai Y, Gao F, Zhang X, Wang L, Tao H.

Cardiovasc Diabetol. 2011 Oct 7;10:87. doi: 10.1186/1475-2840-10-87.

14.

Increased expression and secretion of resistin in epicardial adipose tissue of patients with acute coronary syndrome.

Langheim S, Dreas L, Veschini L, Maisano F, Foglieni C, Ferrarello S, Sinagra G, Zingone B, Alfieri O, Ferrero E, Maseri A, Ruotolo G.

Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H746-53. doi: 10.1152/ajpheart.00617.2009. Epub 2010 Jan 8.

15.

Extension of coronary artery disease is associated with increased IL-6 and decreased adiponectin gene expression in epicardial adipose tissue.

Eiras S, Teijeira-Fernández E, Shamagian LG, Fernandez AL, Vazquez-Boquete A, Gonzalez-Juanatey JR.

Cytokine. 2008 Aug;43(2):174-80. doi: 10.1016/j.cyto.2008.05.006. Epub 2008 Jun 17.

PMID:
18562207
16.

Relationship between epicardial adipose tissue, coronary artery disease and adiponectin in a Mexican population.

Yañez-Rivera TG, Baños-Gonzalez MA, Ble-Castillo JL, Torres-Hernandez ME, Torres-Lopez JE, Borrayo-Sanchez G.

Cardiovasc Ultrasound. 2014 Sep 8;12:35. doi: 10.1186/1476-7120-12-35.

17.

Effects of pioglitazone and/or simvastatin on low density lipoprotein subfractions in non-diabetic patients with high cardiovascular risk: A sub-analysis from the PIOSTAT study.

Leonhardt W, Pfützner A, Müller J, Pietzsch J, Forst T, Karagiannis E, Lübben G, Hanefeld M.

Atherosclerosis. 2008 Nov;201(1):155-62. doi: 10.1016/j.atherosclerosis.2008.01.007. Epub 2008 Apr 18.

PMID:
18374336
18.

Human epicardial adipose tissue is a source of inflammatory mediators.

Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O'Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y.

Circulation. 2003 Nov 18;108(20):2460-6. Epub 2003 Oct 27.

20.

Differential behavior between S100A9 and adiponectin in coronary artery disease. Plasma or epicardial fat.

Agra RM, Teijeira-Fernández E, Pascual-Figal D, Jesús SM, Fernández-Trasancos A, Sierra J, González-Juanatey JR, Eiras S.

Life Sci. 2014 Apr 1;100(2):147-51. doi: 10.1016/j.lfs.2014.02.005. Epub 2014 Feb 16.

PMID:
24548634

Supplemental Content

Support Center